Accelerate Diagnostics Announces Departure of CFO Steve Reichling and Appointment of David Patience As Replacement
Accelerate Diagnostics Announces Departure of CFO Steve Reichling and Appointment of David Patience As Replacement
03/15/23, 12:38 AM
Location
tucson
Industry
biotechnology
Position
head of business development
Accelerate Diagnostics, Inc. a leading provider of innovative rapid diagnostic solutions, announced today that Steve Reichling will be stepping down as Chief Financial Officer , effective March 31, 2023. David Patience, who previously served as Senior Director - Head of Business Development and Strategic Finance has been named as the company's new CFO, effective April 1, 2023.
Company Info
Location
3950 south country club road, suite 470
tucson, arizona, united states
Additional Info
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.